- US-listed companies
- Q BioMed Inc.
- Income statement
Q BioMed Inc. (QBIO) Income statement
Market cap
$144.09
P/E ratio
| 2014/11 | 2016/11 | 2017/11 | 2018/11 | 2019/11 | 2020/11 | 2021/11 | 2022/11 | |
| Revenue | - | - | - | - | - | 30,000 | 195,597 | 284,352 |
| Revenue growth (%) | - | - | - | - | - | - | ||
| Cost of revenue | - | - | - | - | - | 326,009 | 246,846 | 293,340 |
| Gross profit | - | - | - | - | - | -296,009 | -51,249 | -8,988 |
| Gross margin (%) | - | - | - | - | - | |||
| Research & development | - | 1 | 3 | 3 | 4 | 2 | 1 | 125,378 |
| Operating margin (%) | - | - | - | - | - | - | - | |
| Operating expenses | 38,050 | 6 | 12 | 9 | 8 | 13 | 7 | 3 |
| Operating income | -38,050 | - | - | - | - | - | - | -3,445,616 |
| Income before tax | - | - | - | - | - | -13,145,414 | -7,388,565 | - |
| Pretax margin (%) | - | - | - | - | - | -43,818 | -3,777.4 | - |
| Net income | -38,050 | -7,171,511 | -14,541,667 | -9,270,777 | -10,279,730 | -13,492,191 | -8,240,550 | -2,052,093 |
| Net income margin (%) | - | - | - | - | - | |||
| Earnings per share | -0.01 | - | - | - | - | - | -0.33 | -0.08 |
| Diluted EPS | -0.01 | - | - | - | - | - | -0.33 | -0.08 |